David Muzina, M.D.
| Appointed: |
1999 |
| Gender: |
Male |
| Languages: |
English |
Psychiatry and Psychology
Director, Mood Disorders Psychopharmacology Unit
Professional Highlights
- Certified by American Board of Psychiatry and Neurology
Education & Fellowships
| Medical School: | Case Western Reserve University School of Medicine, Cleveland, OH |
|
| Internship: | Cleveland Clinic, Psychiatry, Cleveland, OH |
| Residency: | Cleveland Clinic, Psychiatry, Cleveland, OH |
| Other Education: | (Undergraduate) University of Dayton, Dayton, OH |
Certifications
Specialty Interests
Mood Disorders, bipolar disorder, psychopharmacology, Men's Health, Sports Psychiatry, Primary Care - Behavioral Health Collaborative Care
(Adults only).
Professional Memberships
- American Psychiatric Association
- International Society for Bipolar Disorders
- American Neuropsychiatric Association
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/5/2008, Dr. Muzina has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Muzina receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- AstraZeneca Pharmaceuticals LP
- Pfizer Inc.
- Sepracor
- Wyeth Pharmaceuticals Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
